Hans Prenen

Comparison of multiple protein extraction buffers for GeLC-MS/MS proteomic analysis of liver and colon formalin-fixed, paraffin-embedded tissues.

RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment.

Tumor-associated macrophages: a short compendium.

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.

The potential and controversy of targeting STAT family members in cancer.

Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions.

SARS-CoV-2 and cancer: Are they really partners in crime?

High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!

Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies.

The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic.

RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies.

Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer.

Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests.

Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation.

Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer.

Excellent Response to MEK Inhibition in an Gene Fusion Driven Carcinoma: Case Report and Literature Review.

Targeting hedgehog signaling in pancreatic ductal adenocarcinoma.

Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia.

Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.

Prognostic implications of cellular senescence in resected non-small cell lung cancer.

Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.